Leadership

Leadership and Advisors

Reset Pharma has established a highly experienced biotech team to develop and commercialize innovative and highly effective therapies for demoralization, anxiety and depression in patients with life-threatening cancer and other illnesses. We work with a dedicated group of scientific and strategic advisors who are at the forefront of R&D and bring deep domain experience in psychology, psychiatry and oncology.

Management Team

Jan-Anders Karlsson, Ph.D.

Founder, CEO, and Board Member

Gil Block, M.D, Ph.D.

Chief Medical Officer

Satish Prabhu, C.P.A.

Chief Financial Officer

Åsa Holmgren, M.Sc. Pharm

Regulatory Affairs

Robert Leadbetter

Head of Clinical Development

Board of Directors

Philip Taub

Founder, Board Chair

John Andreadis

Founder, Board Member

Jan-Anders Karlsson, Ph.D.

Founder, CEO, and Board Member

Scientific Advisory Board

Stephen Ross, M.D.

Chair of the Scientific Advisory Board

Anthony Back, M.D.

Scientific Advisory Board

Yvan Beaussant, M.D.

Scientific Advisory Board

Stacy Fischer, M.D.

Scientific Advisory Board

Jim Grigsby, Ph.D.

Scientific Advisory Board

David Hellerstein, M.D.

Scientific Advisory Board

Peter Hendricks, Ph.D.

Scientific Advisory Board

Benjamin Kelmendi, M.D.

Scientific Advisory Board

James A. Tulsky, M.D.

Scientific Advisory Board

Strategic Advisory Board

Mark Corrigan, M.D.

Strategic Advisory Board

Lisa Deschamps

Strategic Advisory Board

Stephen Juelsgaard, D.V.M., J.D.

Strategic Advisory Board

Neil Minkoff, M.D.

Strategic Advisory Board

Brad Sitko

Strategic Advisory Board

Richard A. Yacenda

Strategic Advisory Board